Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.67M Buy
21,171
+849
+4% +$291K 1.92% 16
2026
Q1
$7.15M Buy
20,322
+175
+0.9% +$62.4K 2.13% 16
2025
Q4
$6.62M Buy
20,147
+179
+0.9% +$56.8K 1.97% 16
2025
Q3
$5.63M Buy
19,968
+169
+0.9% +$49K 1.74% 20
2025
Q2
$5.53M Buy
19,799
+4,027
+26% +$1.14M 1.91% 14
2025
Q1
$4.91M Sell
15,772
-84
-0.5% -$24.8K 1.85% 20
2024
Q4
$4.13M Buy
15,856
+1,071
+7% +$318K 1.54% 24
2024
Q3
$4.76M Sell
14,785
-14
-0.1% -$4.58K 1.85% 22
2024
Q2
$4.62M Buy
14,799
+189
+1% +$55.5K 1.95% 15
2024
Q1
$4.15M Buy
14,610
+1,280
+10% +$375K 1.76% 20
2023
Q4
$3.84M Buy
13,330
+8,510
+177% +$2.32M 1.79% 18
2023
Q3
$1.3M Buy
4,820
+3,225
+202% +$805K 0.68% 46
2023
Q2
$354K Sell
1,595
-46
-3% -$10.7K 0.18% 84
2023
Q1
$397K Buy
+1,641
New +$403K 0.23% 81

Other funds holding AMGN

Hudson Value Partners's AMGN Position: Q2 2026 in Review

Hudson Value Partners increased its Amgen (AMGN) stake by 4.2% in Q2 2026, buying an estimated $291K and bringing the position to 21,171 shares worth $7.67M. The position accounts for 1.92% of the portfolio, ranked #16.

Hudson Value Partners first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hudson Value Partners held 21,171 shares of Amgen worth $7.67M as of Q2 2026.
  • Hudson Value Partners bought 849 Amgen shares in Q2 2026, an estimated $291K.
  • Amgen made up 1.92% of Hudson Value Partners's portfolio in Q2 2026, its #16 holding.
  • Hudson Value Partners first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hudson Value Partners's 13F filing for Q2 2026, filed 10 Jul 2026.